108 related articles for article (PubMed ID: 1404649)
1. Malignant Leydig cell tumor of the testis in complete remission on o,p'-dichlorodiphenyl-dichloroethane.
van der Hem KG; Boven E; van Hennik MB; Pinedo HM
J Urol; 1992 Oct; 148(4):1256-9. PubMed ID: 1404649
[TBL] [Abstract][Full Text] [Related]
2. Malignant Leydig cell tumor: objective tumor response to o,p'-DDD.
Azer PC; Braunstein GD
Cancer; 1981 Mar; 47(6):1251-5. PubMed ID: 7226052
[TBL] [Abstract][Full Text] [Related]
3. Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess.
Chortis V; Johal NJ; Bancos I; Evans M; Skordilis K; Guest P; Cullen MH; Porfiri E; Arlt W
Eur J Endocrinol; 2018 Mar; 178(3):K21-K27. PubMed ID: 29330226
[TBL] [Abstract][Full Text] [Related]
4. A high-pressure liquid chromatographic method for measuring mitotane [1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethane] and its metabolite 1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethene in plasma.
Andersen A; Warren DJ; Nome O; Vesterhus L; Slørdal L
Ther Drug Monit; 1995 Oct; 17(5):526-31. PubMed ID: 8585118
[TBL] [Abstract][Full Text] [Related]
5. Recurrent malignant Leydig cell tumor of testis: a case report with review of literature.
Bhat GM; Lone MI; Alsolami S; Iqbal QM
Gulf J Oncolog; 2010 Jan; (7):42-5. PubMed ID: 20164008
[TBL] [Abstract][Full Text] [Related]
6. Treatment of malignant Leydig cell tumor.
Bertram KA; Bratloff B; Hodges GF; Davidson H
Cancer; 1991 Nov; 68(10):2324-9. PubMed ID: 1913469
[TBL] [Abstract][Full Text] [Related]
7. Complete remission of metastasized adrenocortical carcinoma under o,p'-DDD.
Kornely E; Schlaghecke R
Exp Clin Endocrinol; 1994; 102(1):50-3. PubMed ID: 8005209
[TBL] [Abstract][Full Text] [Related]
8. Complete response of metastasized adrenal cortical carcinoma with o,p'-DDD. Case report and literature review.
Boven E; Vermorken JB; van Slooten H; Pinedo HM
Cancer; 1984 Jan; 53(1):26-9. PubMed ID: 6360329
[TBL] [Abstract][Full Text] [Related]
9. Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.
Theile D; Haefeli WE; Weiss J
Endocrine; 2015 Aug; 49(3):842-53. PubMed ID: 25542188
[TBL] [Abstract][Full Text] [Related]
10. High frequency of metastatic Leydig cell testicular tumours.
Farkas LM; Székely JG; Pusztai C; Baki M
Oncology; 2000 Aug; 59(2):118-21. PubMed ID: 10971169
[TBL] [Abstract][Full Text] [Related]
11. Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of Cushing's disease with low doses.
Benecke R; Keller E; Vetter B; de Zeeuw RA
Eur J Clin Pharmacol; 1991; 41(3):259-61. PubMed ID: 1748144
[TBL] [Abstract][Full Text] [Related]
12. Autonomous cortisol secretion by a metastatic Leydig cell carcinoma associated with Klinefelter's syndrome.
Knyrim K; Higi M; Hossfeld DK; Seeber S; Schmidt CG
J Cancer Res Clin Oncol; 1981; 100(1):85-93. PubMed ID: 7016888
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
Dickstein G; Shechner C; Arad E; Best LA; Nativ O
J Clin Endocrinol Metab; 1998 Sep; 83(9):3100-3. PubMed ID: 9745410
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of Cushing's disease with o,p'-DDD followed by pituitary irradiation in a 19-year-old male patient.
Dickerman Z; Kaufman H; Laron Z
Isr J Med Sci; 1979 May; 15(5):455-9. PubMed ID: 447515
[TBL] [Abstract][Full Text] [Related]
15. Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma.
Kroiss M; Plonné D; Kendl S; Schirmer D; Ronchi CL; Schirbel A; Zink M; Lapa C; Klinker H; Fassnacht M; Heinz W; Sbiera S
Eur J Endocrinol; 2016 Mar; 174(3):343-53. PubMed ID: 26671975
[TBL] [Abstract][Full Text] [Related]
16. The distribution of o,p'-DDD (mitotane) among serum lipoproteins in normo- and hypertriglyceridemia.
Gebhardt DO; Moolenaar AJ; van Seters AP; van der Velde EA; Gevers Leuven JA
Cancer Chemother Pharmacol; 1992; 29(4):331-4. PubMed ID: 1537084
[TBL] [Abstract][Full Text] [Related]
17. o,p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacement.
Hogan TF; Citrin DL; Johnson BM; Nakamura S; Davis TE; Borden EC
Cancer; 1978 Nov; 42(5):2177-81. PubMed ID: 719602
[TBL] [Abstract][Full Text] [Related]
18. Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor.
Froehner M; Beuthien-Baumann B; Dittert DD; Schuler U; Wirth MP
Cancer Chemother Pharmacol; 2006 Nov; 58(5):716-8. PubMed ID: 16450163
[TBL] [Abstract][Full Text] [Related]
19. [Malignant Leydig Cell Tumor of the Testis : A Case Report].
Nakai M; Iwasaki H; Fuse H; Ota R; Imamura Y
Hinyokika Kiyo; 2016 May; 62(5):275-8. PubMed ID: 27320121
[TBL] [Abstract][Full Text] [Related]
20. Metachronous germ cell and Leydig cell tumors of the testis. Do testicular germ cell tumors and Leydig cell tumors share common etiologic factors?
Dieckmann KP; Loy V
Cancer; 1993 Aug; 72(4):1305-7. PubMed ID: 8393373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
